FDA notifies veterinarians of adverse events linked to osteoarthritis treatment
In a recent “Dear Veterinarian” letter, the FDA alerted veterinarians of adverse events in dogs treated with bedinvetmab injection (Librela; Zoetis). The monoclonal antibody drug is used to manage pain associated with osteoarthritis in dogs. It is dosed …